Productive HIV-1 infection of primary CD4+ T cells induces mitochondrial membrane permeabilization leading to a caspase-independent cell death.


Autoria(s): Petit F.; Arnoult D.; Lelièvre J.D.; Moutouh-de Parseval L.; Hance A.J.; Schneider P.; Corbeil J.; Ameisen J.C.; Estaquier J.
Data(s)

2002

Resumo

We have explored in vitro the mechanism by which human immunodeficiency virus, type 1 (HIV-1) induces cell death of primary CD4+ T cells in conditions of productive infection. Although HIV-1 infection primed phytohemagglutinin-activated CD4+ T cells for death induced by anti-CD95 antibody, T cell death was not prevented by a CD95-Fc decoy receptor, nor by decoy receptors of other members of the TNFR family (TNFR1/R2, TRAILR1/R2/OPG, TRAMP) or by various blocking antibodies, suggesting that triggering of death receptors by their cognate ligands is not involved in HIV-induced CD4 T cell death. HIV-1 induced CD4 T cell shrinkage, cell surface exposure of phosphatidylserine, loss of mitochondrial membrane potential (Deltapsim), and mitochondrial release of cytochrome c and apoptosis-inducing factor. A typical apoptotic phenotype (nuclear chromatin condensation and fragmentation) only occurred in around half of the dying cells. Treatment with benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone, a broad spectrum caspase inhibitor, prevented nuclear chromatin condensation and fragmentation in HIV-infected CD4+ T cells and in a cell-free system (in which nuclei were incubated with cytoplasmic extracts from the HIV-infected CD4+ T cells). Nevertheless, benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone did not prevent mitochondrial membrane potential loss and cell death, suggesting that caspases are dispensable for HIV-mediated cell death. Our findings suggest a major role of the mitochondria in the process of CD4 T cell death induced by HIV, in which targeting of Bax to the mitochondria may be involved.

Identificador

http://serval.unil.ch/?id=serval:BIB_441A80FF303E

isbn:0021-9258 (Print)

pmid:11689551

doi:10.1074/jbc.M102671200

isiid:000173166800079

Idioma(s)

en

Fonte

Journal of Biological Chemistry, vol. 277, no. 2, pp. 1477-1487

Palavras-Chave #Animals; Antigens, CD95/metabolism; Apoptosis/physiology; Apoptosis Inducing Factor; CD4-Positive T-Lymphocytes/drug effects; CD4-Positive T-Lymphocytes/metabolism; Caspases/antagonists & inhibitors; Caspases/metabolism; Cell Death; Cell-Free System/metabolism; Cells, Cultured; Cysteine Proteinase Inhibitors/metabolism; Cytochrome c Group/metabolism; Enzyme Activation; Flavoproteins/metabolism; Flow Cytometry; HIV-1/physiology; Humans; Inhibitor of Apoptosis Proteins; Interleukin-2/pharmacology; Intracellular Membranes/metabolism; Membrane Proteins/metabolism; Mitochondria/metabolism; Permeability; Phytohemagglutinins/pharmacology; Protein Precursors/metabolism; Proto-Oncogene Proteins/metabolism; Proto-Oncogene Proteins c-bcl-2; Receptors, Tumor Necrosis Factor/metabolism; Viral Proteins/metabolism; bcl-2-Associated X Protein
Tipo

info:eu-repo/semantics/article

article